Eyeworld

OCT 2016

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/733437

Contents of this Issue

Navigation

Page 185 of 186

Post-Cataract Surgery Inflammation/ Corneal Refractive Surgery ASCRS Clinical Survey respondents report an average of 5% of their cataract patients have 1+ cell/flare or greater 3–7 days after cataract surgery. 28% report that 6% or more of their patients experience 1+ cell/flare or greater 3–7 days after surgery. Nearly a fifth of surgeons think it is somewhat not or not important to combine both corticosteroids and NSAIDs to treat postoperative inflammation and control pain following a routine cataract surgery case. More than 30% of ASCRS respondents plan to use intracameral antibiotic injections within the next 12 months. 40% of physicians are currently using intracameral antibiotic injections. Non-U.S. respondents are nearly 75% more likely to use these injections than U.S. respondents. Respondents think that LASIK significantly increases dry eye in an average of 30% of their patients 3 months after surgery. This drops to 25% at 6 months postop. ASCRS 2016 Clinical Survey 7

Articles in this issue

Archives of this issue

view archives of Eyeworld - OCT 2016